Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma.

Deog Hwan Moon(University of California, Los Angeles), Carl K. Hoh(UC San Diego Health System), Daniel Silverman(University of California, Los Angeles), Jamshid Maddahi(University of California, Los Angeles), John A. Glaspy(University of California, Los Angeles), Michael E. Phelps(National Academy of Engineering)
PubMed
March 1, 1998
Cited by 249

Related Papers

Quantitation in Positron Emission Computed Tomography
|Journal of Computer Assisted Tomography|1979|1.2k
Systems Biology and New Technologies Enable Predictive and Preventative Medicine
|Science|2004|1.1k
Positron Emission Tomography in Evaluation of Dementia
|JAMA|2001|952
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
|Proceedings of the National Academy of Sciences|2000|798
PET of Brain Amyloid and Tau in Mild Cognitive Impairment
|New England Journal of Medicine|2006|737